Relmada Therapeutics Inc (RLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -57,385 | -37,517 | -27,426 | -17,560 | -79,979 |
| Accounts payable and accrued liabilities | -2,562 | -2,678 | -2,769 | -2,866 | 625 |
| Other Working Capital | -2,893 | -4,966 | -4,717 | -4,767 | -1,579 |
| Other Operating Activity | 17,053 | 13,971 | 10,443 | 7,125 | 29,178 |
| Operating Cash Flow | $-45,787 | $-31,191 | $-24,469 | $-18,067 | $-51,756 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -48,138 | 28,791 | 22,038 | 15,360 | 51,562 |
| Investing Cash Flow | $-48,138 | $28,791 | $22,038 | $15,360 | $51,562 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 93,638 | 0 | 0 | 0 | 247 |
| Other Financing Activity | -73 | -73 | -73 | 0 | -287 |
| Financing Cash Flow | $93,565 | $-73 | $-73 | $0 | $-40 |
| Beginning Cash Position | 3,857 | 3,857 | 3,857 | 3,857 | 4,092 |
| End Cash Position | 3,497 | 1,385 | 1,353 | 1,150 | 3,857 |
| Net Cash Flow | $-361 | $-2,473 | $-2,504 | $-2,707 | $-235 |
| Free Cash Flow | |||||
| Operating Cash Flow | -45,787 | -31,191 | -24,469 | -18,067 | -51,756 |
| Free Cash Flow | -45,787 | -31,191 | -24,469 | -18,067 | -51,756 |